HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis

35Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Objective-AIDS-related lymphomas are high grade and aggressively metastatic with poor prognosis. Lymphangiogenesis is essential in supporting proliferation and survival of lymphoma, as well as tumor dissemination. Data suggest that aberrant lymphangiogenesis relies on action of HIV-1 proteins rather than on a direct effect of the virus itself. HIV-1 matrix protein p17 was found to accumulate and persist in lymph nodes of patients even under highly active antiretroviral therapy. Because p17 was recently found to exert a potent proangiogenic activity by interacting with chemokine (C-X-C motif) receptors 1 and 2, we tested the prolymphangiogenic activity of the viral protein. Approach and results-Human primary lymph node-derived lymphatic endothelial cells were used to perform capillary-like structure formation, wound healing, spheroids, and Western blot assays after stimulation with or without p17. Here, we show that p17 promotes lymphangiogenesis by binding to chemokine (C-X-C motif) receptor-1 and chemokine (C-X-C motif) receptor-2 expressed on lymph node-derived lymphatic endothelial cells and activating the Akt/extracellular signal-regulated kinase signaling pathway. In particular, it was found to induce capillary-like structure formation, sprout formation from spheroids, and increase lymph node-derived lymphatic endothelial cells motility. The p17 lymphangiogenic activity was, in part, sustained by activation of the endothelin-1/endothelin receptor B axis. A Matrigel plug assay showed that p17 was able to promote the outgrowth of lymphatic vessels in vivo, demonstrating that p17 directly regulates lymphatic vessel formation. Conclusions-Our results suggest that p17 may generate a prolymphangiogenic microenvironment and plays a role in predisposing the lymph node to lymphoma growth and metastasis. This finding offers new opportunities to identify treatment strategies in combating AIDS-related lymphomas. © 2014 American Heart Association, Inc.

References Powered by Scopus

Inflammation and cancer: Back to Virchow?

6789Citations
N/AReaders
Get full text

Lymphangiogenesis and cancer metastasis

709Citations
N/AReaders
Get full text

Cancer burden in the HIV-infected population in the United States

624Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART

310Citations
N/AReaders
Get full text

Oncogenic effects of HIV-1 proteins, mechanisms behind

63Citations
N/AReaders
Get full text

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis

60Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Caccuri, F., Rueckert, C., Giagulli, C., Schulze, K., Basta, D., Zicari, S., … Caruso, A. (2014). HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(4), 846–856. https://doi.org/10.1161/ATVBAHA.113.302478

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

53%

Researcher 6

32%

Professor / Associate Prof. 2

11%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

48%

Agricultural and Biological Sciences 4

19%

Immunology and Microbiology 4

19%

Biochemistry, Genetics and Molecular Bi... 3

14%

Save time finding and organizing research with Mendeley

Sign up for free